AtriCure, Inc. (ATRC)
55.53
+0.39
(+0.71%)
USD |
NASDAQ |
Oct 05, 12:03
AtriCure Enterprise Value : 2.711B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.711B |
| October 01, 2026 | 2.632B |
| September 30, 2026 | 2.765B |
| September 29, 2026 | 2.859B |
| September 28, 2026 | 2.877B |
| September 25, 2026 | 2.876B |
| September 24, 2026 | 2.997B |
| September 23, 2026 | 2.956B |
| September 22, 2026 | 2.899B |
| September 21, 2026 | 2.873B |
| September 18, 2026 | 2.862B |
| September 17, 2026 | 2.913B |
| September 16, 2026 | 2.813B |
| September 15, 2026 | 2.766B |
| September 14, 2026 | 2.744B |
| September 11, 2026 | 2.681B |
| September 10, 2026 | 2.600B |
| September 09, 2026 | 2.604B |
| September 08, 2026 | 2.639B |
| September 04, 2026 | 2.527B |
| September 03, 2026 | 2.575B |
| September 02, 2026 | 2.581B |
| September 01, 2026 | 2.395B |
| August 31, 2026 | 2.366B |
| August 28, 2026 | 2.375B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.412B |
| August 26, 2026 | 2.357B |
| August 25, 2026 | 2.382B |
| August 24, 2026 | 2.413B |
| August 21, 2026 | 2.398B |
| August 20, 2026 | 2.322B |
| August 19, 2026 | 2.328B |
| August 18, 2026 | 2.234B |
| August 17, 2026 | 2.184B |
| August 14, 2026 | 2.160B |
| August 13, 2026 | 2.118B |
| August 12, 2026 | 2.122B |
| August 11, 2026 | 2.091B |
| August 10, 2026 | 2.024B |
| August 07, 2026 | 2.012B |
| August 06, 2026 | 1.915B |
| August 05, 2026 | 1.907B |
| August 04, 2026 | 1.890B |
| August 03, 2026 | 1.876B |
| July 31, 2026 | 1.827B |
| July 30, 2026 | 1.949B |
| July 29, 2026 | 1.986B |
| July 28, 2026 | 1.928B |
| July 27, 2026 | 1.807B |
| July 24, 2026 | 1.689B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 196.37B |
| Boston Scientific Corp. | 73.85B |
| AngioDynamics, Inc. | 587.18M |
| Alphatec Holdings, Inc. | 2.040B |
| Baxter International, Inc. | 18.82B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 8.955M |
| Revenue (Quarterly) | 153.60M |
| Total Expenses (Quarterly) | 144.65M |
| EPS Diluted (Quarterly) | 0.1832 |
| Gross Profit Margin (Quarterly) | 76.75% |
| Profit Margin (Quarterly) | 5.83% |
| Earnings Yield | 0.39% |
| Operating Earnings Yield | 0.52% |
| Normalized Earnings Yield | 0.4162 |